Q03518 (TAP1_HUMAN) Reviewed, UniProtKB/Swiss-Prot
Last modified
May 1, 2013.
Version 146.
History...
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize order
Names·Attributes·General annotation·Ontologies·Interactions·Sequence annotation·Sequences·References·Web links·Cross-refs·Entry info·DocumentsCustomize orderNames and origin
| Protein names | Recommended name: Antigen peptide transporter 1 Short name=APT1 Alternative name(s): ATP-binding cassette sub-family B member 2 Peptide supply factor 1 Peptide transporter PSF1 Short name=PSF-1 Peptide transporter TAP1 Peptide transporter involved in antigen processing 1 Really interesting new gene 4 protein | ||||
| Gene names |
| ||||
| Organism | Homo sapiens (Human) [Reference proteome] | ||||
| Taxonomic identifier | 9606 [NCBI] | ||||
| Taxonomic lineage | Eukaryota › Metazoa › Chordata › Craniata › Vertebrata › Euteleostomi › Mammalia › Eutheria › Euarchontoglires › Primates › Haplorrhini › Catarrhini › Hominidae › Homo![]() |
Protein attributes
| Sequence length | 808 AA. |
| Sequence status | Complete. |
| Protein existence | Evidence at protein level |
General annotation (Comments)
| Function | Involved in the transport of antigens from the cytoplasm to the endoplasmic reticulum for association with MHC class I molecules. Also acts as a molecular scaffold for the final stage of MHC class I folding, namely the binding of peptide. Nascent MHC class I molecules associate with TAP via tapasin. Inhibited by the covalent attachment of herpes simplex virus ICP47 protein, which blocks the peptide-binding site of TAP. Inhibited by human cytomegalovirus US6 glycoprotein, which binds to the lumenal side of the TAP complex and inhibits peptide translocation by specifically blocking ATP-binding to TAP1 and prevents the conformational rearrangement of TAP induced by peptide binding. Inhibited by human adenovirus E3-19K glycoprotein, which binds the TAP complex and acts as a tapasin inhibitor, preventing MHC class I/TAP association. Expression of TAP1 is down-regulated by human Epstein-Barr virus vIL-10 protein, thereby affecting the transport of peptides into the endoplasmic reticulum and subsequent peptide loading by MHC class I molecules. |
| Subunit structure | Heterodimer of TAP1 and TAP2. Interacts with Epstein-Barr virus BNLF2a. Interacts with PSMB5 and PSMB8. Ref.18 Ref.19 |
| Subcellular location | Endoplasmic reticulum membrane; Multi-pass membrane protein. Note: The transmembrane segments seem to form a pore in the membrane. |
| Induction | By IFNG/IFN-gamma. Ref.13 |
| Domain | The peptide-binding site is shared between the cytoplasmic loops of TAP1 and TAP2. |
| Polymorphism | There are five common alleles; TAP1*01:01 (PSF1A), TAP1*02:01 (PSF1B), TAP1*03:01 (PSF1C), TAP1*01:04 and TAP1*x. The sequence of TAP1*01:01 is shown here. |
| Involvement in disease | Bare lymphocyte syndrome 1 (BLS1) [MIM:604571]: A HLA class I deficiency. Contrary to bare lymphocyte syndromes type 2 and type 3, which are characterized by early-onset severe combined immunodeficiency, class I antigen deficiencies are not accompanied by particular pathologic manifestations during the first years of life. Systemic infections have not been described. Chronic bacterial infections, often beginning in the first decade of life, are restricted to the respiratory tract. |
| Sequence similarities | Belongs to the ABC transporter superfamily. ABCB family. MHC peptide exporter (TC 3.A.1.209) subfamily. [View classification] Contains 1 ABC transmembrane type-1 domain. Contains 1 ABC transporter domain. |
| Caution | It is uncertain whether Met-1 or Met-61 is the initiator. |
| Sequence caution | The sequence CAA47025.1 differs from that shown. Reason: Erroneous initiation. The sequence CAA60785.1 differs from that shown. Reason: Erroneous initiation. |
Ontologies
Binary interactions
With | Entry | #Exp. | IntAct | Notes |
|---|---|---|---|---|
| CALR | P27797 | 2 | EBI-747259,EBI-1049597 | |
| P4HB | P07237 | 4 | EBI-747259,EBI-395883 | |
| PDIA3 | P30101 | 4 | EBI-747259,EBI-979862 | |
| TAP2 | Q03519 | 6 | EBI-747259,EBI-780781 | |
| TAPBP | O15533 | 7 | EBI-747259,EBI-874801 |
Sequence annotation (Features)
| Feature key | Position(s) | Length | Description | Graphical view | Feature identifier | |||||||||||||||||||||||||||||||||||||||||||||||||||
Molecule processing | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Chain | 1 – 808 | 808 | Antigen peptide transporter 1 | PRO_0000093326 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Regions | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 61 – 75 | 15 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 76 – 96 | 21 | Helical; Name=1; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 97 – 113 | 17 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 114 – 136 | 23 | Helical; Name=2; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 137 – 152 | 16 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 153 – 173 | 21 | Helical; Name=3; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 174 – 193 | 20 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 194 – 214 | 21 | Helical; Name=4; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 215 – 246 | 32 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 247 – 267 | 21 | Helical; Name=5; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 268 – 287 | 20 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 288 – 308 | 21 | Helical; Name=6; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 309 – 358 | 50 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 359 – 379 | 21 | Helical; Name=7; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 380 – 388 | 9 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 389 – 409 | 21 | Helical; Name=8; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 410 – 478 | 69 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 479 – 499 | 21 | Helical; Name=9; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 500 – 503 | 4 | Lumenal Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Transmembrane | 504 – 524 | 21 | Helical; Name=10; Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Topological domain | 525 – 808 | 284 | Cytoplasmic Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 247 – 530 | 284 | ABC transmembrane type-1 | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Domain | 563 – 802 | 240 | ABC transporter | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Nucleotide binding | 598 – 605 | 8 | ATP Potential | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 435 – 480 | 46 | Involved in peptide-binding site | |||||||||||||||||||||||||||||||||||||||||||||||||||||
| Region | 513 – 547 | 35 | Involved in peptide-binding site | |||||||||||||||||||||||||||||||||||||||||||||||||||||
Natural variations | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 67 | 1 | P → S. Ref.25 | VAR_016801 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 77 | 1 | G → R. Ref.25 Corresponds to variant rs57640466 [ dbSNP | Ensembl ]. | VAR_016802 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 170 | 1 | L → V. Corresponds to variant rs2228108 [ dbSNP | Ensembl ]. | VAR_048137 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 304 | 1 | V → L. Corresponds to variant rs36229525 [ dbSNP | Ensembl ]. | VAR_060987 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 346 | 1 | S → F. Corresponds to variant rs2228111 [ dbSNP | Ensembl ]. | VAR_048138 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 393 | 1 | I → V in allele TAP1*02:01, allele TAP1*03:01, allele TAP1*04:01 and allele TAP1*x. Ref.7 Ref.22 Ref.24 Ref.25 Corresponds to variant rs1057141 [ dbSNP | Ensembl ]. | VAR_000092 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 430 | 1 | A → V in allele TAP1*x. Ref.24 Ref.25 Corresponds to variant rs2127679 [ dbSNP | Ensembl ]. | VAR_013151 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 479 | 1 | G → C. Ref.25 Corresponds to variant rs2228110 [ dbSNP | Ensembl ]. | VAR_016803 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 518 | 1 | V → L in allele TAP1*04:01. Ref.7 Ref.24 Ref.25 Corresponds to variant rs41550019 [ dbSNP | Ensembl ]. | VAR_013152 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 578 | 1 | V → I in allele TAP1*x. Ref.24 Corresponds to variant rs41561219 [ dbSNP | Ensembl ]. | VAR_013153 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 697 | 1 | D → G in allele TAP1*02:01, allele TAP1*04:01 and allele TAP1*x. Ref.7 Ref.9 Ref.22 Ref.24 Ref.25 Corresponds to variant rs1135216 [ dbSNP | Ensembl ]. | VAR_000093 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 708 | 1 | R → Q in allele TAP1*04:01. Ref.7 Ref.9 Ref.24 Ref.25 Corresponds to variant rs1057149 [ dbSNP | Ensembl ]. | VAR_013154 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 719 | 1 | R → Q in a lung cancer cell line deficient in MHC class I presentation. Ref.23 | VAR_013173 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
| Natural variant | 768 | 1 | Q → R. Corresponds to variant rs1057149 [ dbSNP | Ensembl ]. | VAR_047514 | ||||||||||||||||||||||||||||||||||||||||||||||||||||
Secondary structure | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Helix Strand Turn | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 563 – 570 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 580 – 588 | 9 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 593 – 597 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 604 – 611 | 8 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 618 – 624 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 629 – 631 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 634 – 640 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 641 – 644 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 652 – 654 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 655 – 660 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 669 – 678 | 10 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 682 – 686 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 691 – 693 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 701 – 703 | 3 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 705 – 717 | 13 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 722 – 728 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Turn | 729 – 732 | 4 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 735 – 746 | 12 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 749 – 753 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 755 – 759 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 763 – 767 | 5 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 770 – 776 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Beta strand | 779 – 784 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 786 – 792 | 7 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Helix | 795 – 800 | 6 | ||||||||||||||||||||||||||||||||||||||||||||||||||||||
Sequences
| ||||||||||||||||||
References
| « Hide 'large scale' references | |
| [1] | "Sequences encoded in the class II region of the MHC related to the 'ABC' superfamily of transporters." Trowsdale J., Hanson I., Mockridge I., Beck S., Townsend A., Kelly A. Nature 348:741-744(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA]. |
| [2] | "DNA sequence analysis of 66 kb of the human MHC class II region encoding a cluster of genes for antigen processing." Beck S., Kelly A., Radley E., Khurshid F., Alderton R.P., Trowsdale J. J. Mol. Biol. 228:433-441(1992) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [3] | "Evolutionary dynamics of non-coding sequences within the class II region of the human MHC." Beck S., Abdulla S., Alderton R.P., Glynne R.J., Gut I.G., Hosking L.K., Jackson A., Kelly A., Newell W.R., Sanseau P., Radley E., Thorpe K.L., Trowsdale J. J. Mol. Biol. 255:1-13(1996) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [GENOMIC DNA]. |
| [4] | "The DNA sequence and analysis of human chromosome 6." Mungall A.J., Palmer S.A., Sims S.K., Edwards C.A., Ashurst J.L., Wilming L., Jones M.C., Horton R., Hunt S.E., Scott C.E., Gilbert J.G.R., Clamp M.E., Bethel G., Milne S., Ainscough R., Almeida J.P., Ambrose K.D., Andrews T.D. Beck S.Nature 425:805-811(2003) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [5] | Mural R.J., Istrail S., Sutton G.G., Florea L., Halpern A.L., Mobarry C.M., Lippert R., Walenz B., Shatkay H., Dew I., Miller J.R., Flanigan M.J., Edwards N.J., Bolanos R., Fasulo D., Halldorsson B.V., Hannenhalli S., Turner R. Venter J.C.Submitted (JUL-2005) to the EMBL/GenBank/DDBJ databases Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA]. |
| [6] | "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)." The MGC Project Team Genome Res. 14:2121-2127(2004) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA]. Tissue: Uterus. |
| [7] | "TAP1 alleles in insulin-dependent diabetes mellitus: a newly defined centromeric boundary of disease susceptibility." Jackson D.G., Capra J.D. Proc. Natl. Acad. Sci. U.S.A. 90:11079-11083(1993) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 61-808, VARIANTS VAL-393; LEU-518; GLY-697 AND GLN-708. Tissue: Blood. |
| [8] | "A gene in the human major histocompatibility complex class II region controlling the class I antigen presentation pathway." Spies T., Bresnahan M., Bahram S., Arnold D., Blanck G., Mellins E., Pious D., Demars R. Nature 348:744-747(1990) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 183-612. |
| [9] | "New allelic polymorphisms in TAP genes." Szafer F., Oksenberg J.R., Steinman L. Immunogenetics 39:374-374(1994) [PubMed] [Europe PMC] [Abstract] Cited for: NUCLEOTIDE SEQUENCE [MRNA] OF 691-723, VARIANTS GLY-697 AND GLN-708. |
| [10] | "Two putative subunits of a peptide pump encoded in the human major histocompatibility complex class II region." Bahram S., Arnold D., Bresnahan M., Strominger J.L., Spies T. Proc. Natl. Acad. Sci. U.S.A. 88:10094-10098(1991) [PubMed] [Europe PMC] [Abstract] Cited for: TISSUE SPECIFICITY. |
| [11] | "Molecular mechanism and species specificity of TAP inhibition by herpes simplex virus ICP47." Ahn K., Meyer T.H., Uebel S., Sempe P., Djaballah H., Yang Y., Peterson P.A., Frueh K., Tampe R. EMBO J. 15:3247-3255(1996) [PubMed] [Europe PMC] [Abstract] Cited for: INHIBITION BY ICP47. |
| [12] | "Multiple regions of the transporter associated with antigen processing (TAP) contribute to its peptide binding site." Nijenhuis M., Hammerling G.J. J. Immunol. 157:5467-5477(1996) [PubMed] [Europe PMC] [Abstract] Cited for: PEPTIDE-BINDING SITE. |
| [13] | "Downregulation of TAP1 in B lymphocytes by cellular and Epstein-Barr virus-encoded interleukin-10." Zeidler R., Eissner G., Meissner P., Uebel S., Tampe R., Lazis S., Hammerschmidt W. Blood 90:2390-2397(1997) [PubMed] [Europe PMC] [Abstract] Cited for: DOWN-REGULATION BY VIRAL IL-10. |
| [14] | "The ER-luminal domain of the HCMV glycoprotein US6 inhibits peptide translocation by TAP." Ahn K., Gruhler A., Galocha B., Jones T.R., Wiertz E.J.H.J., Ploegh H.L., Peterson P.A., Yang Y., Frueh K. Immunity 6:613-621(1997) [PubMed] [Europe PMC] [Abstract] Cited for: INHIBITION BY US6 GLYCOPROTEIN. |
| [15] | "Splice acceptor site mutation of the transporter associated with antigen processing-1 gene in human bare lymphocyte syndrome." Furukawa H., Murata S., Yabe T., Shimbara N., Keicho N., Kashiwase K., Watanabe K., Ishikawa Y., Akaza T., Tadokoro K., Tohma S., Inoue T., Tokunaga K., Yamamoto K., Tanaka K., Juji T. J. Clin. Invest. 103:755-758(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INVOLVEMENT IN BLS1. |
| [16] | "Adenovirus E19 has two mechanisms for affecting class I MHC expression." Bennett E.M., Bennink J.R., Yewdell J.W., Brodsky F.M. J. Immunol. 162:5049-5052(1999) [PubMed] [Europe PMC] [Abstract] Cited for: INHIBITION BY E3-19K GLYCOPROTEIN. |
| [17] | "The human cytomegalovirus gene product US6 inhibits ATP binding by TAP." Hewitt E.W., Gupta S.S., Lehner P.J. EMBO J. 20:387-396(2001) [PubMed] [Europe PMC] [Abstract] Cited for: INHIBITION BY US6 GLYCOPROTEIN. |
| [18] | "Cytoplasmic domains of the transporter associated with antigen processing and P-glycoprotein interact with subunits of the proteasome." Begley G.S., Horvath A.R., Taylor J.C., Higgins C.F. Mol. Immunol. 42:137-141(2005) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH PSMB5 AND PSMB8. |
| [19] | "Specific targeting of the EBV lytic phase protein BNLF2a to the transporter associated with antigen processing results in impairment of HLA class I-restricted antigen presentation." Horst D., van Leeuwen D., Croft N.P., Garstka M.A., Hislop A.D., Kremmer E., Rickinson A.B., Wiertz E.J.H.J., Ressing M.E. J. Immunol. 182:2313-2324(2009) [PubMed] [Europe PMC] [Abstract] Cited for: INTERACTION WITH EBV BNLF2A. |
| [20] | "Initial characterization of the human central proteome." Burkard T.R., Planyavsky M., Kaupe I., Breitwieser F.P., Buerckstuemmer T., Bennett K.L., Superti-Furga G., Colinge J. BMC Syst. Biol. 5:17-17(2011) [PubMed] [Europe PMC] [Abstract] Cited for: IDENTIFICATION BY MASS SPECTROMETRY [LARGE SCALE ANALYSIS]. |
| [21] | "Structure of the ABC ATPase domain of human TAP1, the transporter associated with antigen processing." Gaudet R., Wiley D.C. EMBO J. 20:4964-4972(2001) [PubMed] [Europe PMC] [Abstract] Cited for: X-RAY CRYSTALLOGRAPHY (2.4 ANGSTROMS) OF 549-808. |
| [22] | "Allelic variants of the human putative peptide transporter involved in antigen processing." Colonna M., Bresnahan M., Bahram S., Strominger J.L., Spies T. Proc. Natl. Acad. Sci. U.S.A. 89:3932-3936(1992) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS VAL-393 AND GLY-697. |
| [23] | "A functionally defective allele of TAP1 results in loss of MHC class I antigen presentation in a human lung cancer." Chen H.L., Gabrilovich D., Tampe R., Girgis K.R., Nadaf S., Carbone D.P. Nat. Genet. 13:210-213(1996) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANT GLN-719. |
| [24] | "TAP1 polymorphisms in several human ethnic groups: characteristics, evolution, and genotyping strategies." Tang J., Freedman D.O., Allen S., Karita E., Musonda R., Braga C., Margolick J., Kaslow R.A. Hum. Immunol. 62:256-268(2001) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS VAL-393; VAL-430; LEU-518; ILE-578; GLY-697 AND GLN-708. |
| [25] | "Novel TAP1 polymorphisms in indigenous Zimbabweans: their potential implications on TAP function and in human diseases." Lajoie J., Zijenah L.S., Faucher M.C., Ward B.J., Roger M. Hum. Immunol. 64:823-829(2003) [PubMed] [Europe PMC] [Abstract] Cited for: VARIANTS SER-67; ARG-77; VAL-393; VAL-430; CYS-479; LEU-518; GLY-697 AND GLN-708. |
| + | Additional computationally mapped references. |
Cross-references
Sequence databases | |||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| EMBL GenBank DDBJ | X57522 mRNA. Translation: CAA40741.1. X66401 Genomic DNA. Translation: CAA47025.1. Different initiation. X87344 Genomic DNA. Translation: CAA60785.1. Different initiation. AL669918 Genomic DNA. Translation: CAI18140.1. AL671681 Genomic DNA. Translation: CAI17714.1. AL935043 Genomic DNA. Translation: CAI18626.1. BX927138 Genomic DNA. Translation: CAQ08449.1. CR762476 Genomic DNA. Translation: CAQ08495.1. CR933844 Genomic DNA. Translation: CAQ08906.1. CR753889 Genomic DNA. Translation: CAQ10287.1. CH471081 Genomic DNA. Translation: EAX03647.1. BC014081 mRNA. Translation: AAH14081.1. L21204 mRNA. Translation: AAC12902.1. L21205 mRNA. Translation: AAC12903.1. L21206 mRNA. Translation: AAC12904.1. L21207 mRNA. Translation: AAC12905.1. L21208 mRNA. Translation: AAC12906.1. X57521 mRNA. Translation: CAA40740.1. S70274 mRNA. Translation: AAD14056.1. | ||||||||||||
| IPI | IPI00646625. | ||||||||||||
| PIR | A41538. S13427. | ||||||||||||
| RefSeq | NP_000584.2. NM_000593.5. | ||||||||||||
| UniGene | Hs.352018. | ||||||||||||
3D structure databases | |||||||||||||
| PDBe RCSB PDB PDBj |
| ||||||||||||
| ProteinModelPortal | Q03518. | ||||||||||||
| ModBase | Search... | ||||||||||||
Protein-protein interaction databases | |||||||||||||
| DIP | DIP-35626N. | ||||||||||||
| IntAct | Q03518. 13 interactions. | ||||||||||||
| MINT | MINT-1477433. | ||||||||||||
| STRING | 9606.ENSP00000346206. | ||||||||||||
Protein family/group databases | |||||||||||||
| TCDB | 3.A.1.209.1. ATP-binding cassette (ABC) superfamily. | ||||||||||||
PTM databases | |||||||||||||
| PhosphoSite | Q03518. | ||||||||||||
Polymorphism databases | |||||||||||||
| DMDM | 215273957. | ||||||||||||
Proteomic databases | |||||||||||||
| PaxDb | Q03518. | ||||||||||||
| PRIDE | Q03518. | ||||||||||||
Protocols and materials databases | |||||||||||||
| DNASU | 6890. | ||||||||||||
| StructuralBiologyKnowledgebase | Search... | ||||||||||||
Genome annotation databases | |||||||||||||
| Ensembl | ENST00000354258; ENSP00000346206; ENSG00000168394. ENST00000383235; ENSP00000372722; ENSG00000206297. ENST00000414467; ENSP00000405356; ENSG00000226173. ENST00000418205; ENSP00000401149; ENSG00000227816. ENST00000424897; ENSP00000413080; ENSG00000230705. ENST00000439781; ENSP00000415660; ENSG00000224212. ENST00000440894; ENSP00000402316; ENSG00000232367. | ||||||||||||
| GeneID | 6890. | ||||||||||||
| KEGG | hsa:6890. | ||||||||||||
| UCSC | uc003ocg.3. human. | ||||||||||||
Organism-specific databases | |||||||||||||
| CTD | 6890. | ||||||||||||
| GeneCards | GC06M032812. | ||||||||||||
| HGNC | HGNC:43. TAP1. | ||||||||||||
| HPA | CAB009516. | ||||||||||||
| MIM | 170260. gene. 604571. phenotype. | ||||||||||||
| neXtProt | NX_Q03518. | ||||||||||||
| Orphanet | 34592. Immunodeficiency by defective expression of HLA class 1. | ||||||||||||
| PharmGKB | PA35021. | ||||||||||||
| GenAtlas | Search... | ||||||||||||
Phylogenomic databases | |||||||||||||
| eggNOG | COG1132. | ||||||||||||
| HOVERGEN | HBG008358. | ||||||||||||
| InParanoid | Q03518. | ||||||||||||
| KO | K05653. | ||||||||||||
| OMA | LPLLRVW. | ||||||||||||
| OrthoDB | EOG4KPT98. | ||||||||||||
| PhylomeDB | Q03518. | ||||||||||||
Enzyme and pathway databases | |||||||||||||
| BRENDA | 3.6.3.43. 2681. | ||||||||||||
| Reactome | REACT_6900. Immune System. | ||||||||||||
Gene expression databases | |||||||||||||
| ArrayExpress | Q03518. | ||||||||||||
| Bgee | Q03518. | ||||||||||||
| CleanEx | HS_TAP1. | ||||||||||||
| Genevestigator | Q03518. | ||||||||||||
| GermOnline | ENSG00000168394. Homo sapiens. | ||||||||||||
Family and domain databases | |||||||||||||
| InterPro | IPR003593. AAA+_ATPase. IPR013305. ABC_B2. IPR003439. ABC_transporter-like. IPR017871. ABC_transporter_CS. IPR017940. ABC_transporter_type1. IPR001140. ABC_transptr_TM_dom. IPR011527. ABC_transptrTM_dom_typ1. IPR005293. Ag_transporter2. [Graphical view] | ||||||||||||
| Pfam | PF00664. ABC_membrane. 1 hit. PF00005. ABC_tran. 1 hit. [Graphical view] | ||||||||||||
| PRINTS | PR01896. TAP1PROTEIN. | ||||||||||||
| SMART | SM00382. AAA. 1 hit. [Graphical view] | ||||||||||||
| SUPFAM | SSF90123. ABC_TM_1. 1 hit. | ||||||||||||
| TIGRFAMs | TIGR00958. 3a01208. 1 hit. | ||||||||||||
| PROSITE | PS50929. ABC_TM1F. 1 hit. PS00211. ABC_TRANSPORTER_1. 1 hit. PS50893. ABC_TRANSPORTER_2. 1 hit. [Graphical view] | ||||||||||||
| ProtoNet | Search... | ||||||||||||
Other | |||||||||||||
| EvolutionaryTrace | Q03518. | ||||||||||||
| GenomeRNAi | 6890. | ||||||||||||
| NextBio | 26925. | ||||||||||||
| SOURCE | Search... | ||||||||||||
Entry information
| Entry name | TAP1_HUMAN | ||||||||
| Accession | Primary (citable) accession number: Q03518 Secondary accession number(s): Q16149, Q96CP4 | ||||||||
| Entry history |
| ||||||||
| Entry status | Reviewed (UniProtKB/Swiss-Prot) | ||||||||
| Annotation program | Chordata Protein Annotation Program | ||||||||
| Disclaimer | Any medical or genetic information present in this entry is provided for research, educational and informational purposes only. It is not in any way intended to be used as a substitute for professional medical advice, diagnosis, treatment or care. | ||||||||
Relevant documents
| Human chromosome 6 Human chromosome 6: entries, gene names and cross-references to MIM |
| Human entries with polymorphisms or disease mutations List of human entries with polymorphisms or disease mutations |
| Human polymorphisms and disease mutations Index of human polymorphisms and disease mutations |
| MIM cross-references Online Mendelian Inheritance in Man (MIM) cross-references in UniProtKB/Swiss-Prot |
| PDB cross-references Index of Protein Data Bank (PDB) cross-references |
| SIMILARITY comments Index of protein domains and families |

Clusters with
